FDA Approves Jatenzo (testosterone undecanoate) for Certain Forms of Hypogonadism

Article Link: FDA Approves Jatenzo (testosterone undecanoate) for Certain Forms of Hypogonadism

March 27, 2019 — The U.S. Food and Drug Administration today approved Jatenzo (testosterone undecanoate), an oral testosterone capsule to treat men with certain forms of hypogonadism. These men have low testosterone levels due to specific medical…

Source: FDA New Drug Approvals